Radiopharm Theranostics 6-K Report: February 2025 Announcement Highlights

Here are the key insights and information extracted from the provided section of the financial report:

1. Company Information:

• Name: Radiopharm Theranostics Limited
• Commission File Number: 001-41621
• Address: Level 3, 62 Lygon Street, Carlton South, Victoria 3053, Australia

2. Filing Type:

• Form: 6-K (Report of Foreign Private Issuer)
• Relevant Regulation: Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

3. Reporting Period:

• For the Month: February 2025

4. Public Announcement:

• The company published an announcement titled: "RAD to present at TD Cowen Annual Healthcare Conference" on February 24, 2025.
• This announcement was disclosed to the Australian Securities Exchange.

5. Exhibit Information:

• The public notice is attached as an exhibit to this report on Form 6-K.
• Exhibit Number: 99.1
• Exhibit Description: RAD to present at TD Cowen Annual Healthcare Conference.

6. Signatory:

• The report was signed by Phillip Hains, who is the Company Secretary.
• Signature Date: February 24, 2025.

7. Regulatory Context:

• The report clarifies that it should not be deemed "filed" for purposes of the Securities Exchange Act of 1934 and will not be incorporated by reference into any filing under the Securities Act of 1933 unless expressly stated.

This summary highlights the essential details regarding the company’s recent activities and compliance reporting as required by securities regulation.